Related references
Note: Only part of the references are listed.Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Cell-surface heparan sulfate proteoglycans as multifunctional integrators of signaling in cancer
Nourhan Hassan et al.
CELLULAR SIGNALLING (2021)
Pathological Angiogenesis Requires Syndecan-4 for Efficient VEGFA-Induced VE-Cadherin Internalization
Giulia De Rossi et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)
Role of cell surface proteoglycans in cancer immunotherapy
Nancy A. Espinoza-Sanchez et al.
SEMINARS IN CANCER BIOLOGY (2020)
Antibody-mediated inhibition of syndecan-4 dimerisation reduces interleukin (IL)-1 receptor trafficking and signalling
Lars Godmann et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Challenges in liver cancer and possible treatment approaches
David Anwanwan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2020)
Cell adhesion in cancer: Beyond the migration of single cells
Michalina Janiszewska et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
ERK/MAPK signalling pathway and tumorigenesis
Yan-Jun Guo et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2020)
ADAMTS-1 and syndecan-4 intersect in the regulation of cell migration and angiogenesis
Jordi Lambert et al.
JOURNAL OF CELL SCIENCE (2020)
Impact of Extracellular Matrix Components to Renal Cell Carcinoma Behavior
Sandra Majo et al.
FRONTIERS IN ONCOLOGY (2020)
HS2ST1-dependent signaling pathways determine breast cancer cell viability, matrix interactions, and invasive behavior
Archana Vijaya Kumar et al.
CANCER SCIENCE (2020)
The Ehlers-Danlos syndromes
Fransiska Malfait et al.
NATURE REVIEWS DISEASE PRIMERS (2020)
Targeting the Tumor Microenvironment in Neuroblastoma: Recent Advances and Future Directions
Shweta Joshi
CANCERS (2020)
Targeting Metabolic Pathways in Kidney Cancer Rationale and Therapeutic Opportunities
Christian R. Hoerner et al.
CANCER JOURNAL (2020)
Syndecan-4/PAR-3 signaling regulates focal adhesion dynamics in mesenchymal cells
Alejandra Valdivia et al.
CELL COMMUNICATION AND SIGNALING (2020)
Syndecan-I modulates the invasive potential of endometrioma via TGF-β signalling in a subgroup of women with endometriosis
Sakthivignesh Ponandai-Srinivasan et al.
HUMAN REPRODUCTION (2020)
Bone Microenvironment and Osteosarcoma Metastasis
Chaofei Yang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Probing the recognition specificity of αVβ1 integrin and syndecan-4 using force spectroscopy
Malgorzata Lekka et al.
MICRON (2020)
The Heparan Sulfate Sulfotransferases HS2ST1 and HS3ST2 Are Novel Regulators of Breast Cancer Stem-Cell Properties
Felipe C. O. B. Teixeira et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Syndecan-4 Modulates Cell Polarity and Migration by Influencing Centrosome Positioning and Intracellular Calcium Distribution
Daniel Becsky et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
Bladder Cancer: A Review
Andrew T. Lenis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Effects of syndecan-4 gene silencing by micro RNA interference in anoikis resistant endothelial cells Syndecan-4 silencing and anoikis resistance
Jessica Oyie Sousa Onyeisi et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2020)
HER2-mediated GLI2 stabilization promotes anoikis resistance and metastasis of breast cancer cells
Parul Gupta et al.
CANCER LETTERS (2019)
Structures and interactions of syndecans
Frank Gondelaud et al.
FEBS JOURNAL (2019)
Heparan sulfate proteoglycans as trastuzumab targets in anoikis-resistant endothelial cells
Jessica Oyie Sousa Onyeisi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Thrombin-cleaved syndecan-3/-4 ectodomain fragments mediate endothelial barrier dysfunction
Melanie Jannaway et al.
PLOS ONE (2019)
Capture and Detection of Circulating Glioma Cells Using the Recombinant VAR2CSA Malaria Protein
Sara R. Bang-Christensen et al.
CELLS (2019)
Sulfated Glycoaminoglycans and Proteoglycan Syndecan-4 Are Involved in Membrane Fixation of LL-37 and Its Pro-Migratory Effect in Breast Cancer Cells
Chahrazed Habes et al.
BIOMOLECULES (2019)
Gene expression profiling identifies potential molecular markers of papillary thyroid carcinoma
Ismael Reyes et al.
CANCER BIOMARKERS (2019)
Differential Subcellular Localization Regulates Oncogenic Signaling by ROS1 Kinase Fusion Proteins
Dana S. Neel et al.
CANCER RESEARCH (2019)
New Anti-Cancer Strategies in Testicular Germ Cell Tumors
Paolo Chieffi et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2019)
Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations
Mardiaty Iryani Abdullah et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2019)
Prognostic markers in clinical stage I seminoma and nonseminomatous germ cell tumours
Adriana M. Pedraza et al.
CURRENT OPINION IN UROLOGY (2018)
Heparan Sulfate Proteoglycans in Human Colorectal Cancer
Carolina Meloni Vicente et al.
ANALYTICAL CELLULAR PATHOLOGY (2018)
Integrated Molecular Characterization of Testicular Germ Cell Tumors
Hui Shen et al.
CELL REPORTS (2018)
Identification of key genes of papillary thyroid cancer using integrated bioinformatics analysis
W. Liang et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2018)
Proteoglycan Chemical Diversity Drives Multifunctional Cell Regulation and Therapeutics
Nikos K. Kararnanos et al.
CHEMICAL REVIEWS (2018)
Syndecan-4 influences mammalian myoblast proliferation by modulating myostatin signalling and G1/S transition
Aniko Keller-Pinter et al.
FEBS LETTERS (2018)
Extracellular histones are the ligands for the uptake of exosomes and hydroxyapatite-nanoparticles by tumor cells via syndecan-4
Josiah Ochieng et al.
FEBS LETTERS (2018)
Autotaxin-β interaction with the cell surface via syndecan-4 impacts on cancer cell proliferation and metastasis
Raphael Leblanc et al.
Oncotarget (2018)
Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and Progression
Arvindhan Nagarajan et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Proteoglycans Are Attractive Biomarkers and Therapeutic Targets in Hepatocellular Carcinoma
Yasuo Tanaka et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis
Yixiao Feng et al.
GENES & DISEASES (2018)
11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial
David Cameron et al.
LANCET (2017)
Coupling of vinculin to F-actin demands Syndecan-4 proteoglycan
R. P. Cavalheiro et al.
MATRIX BIOLOGY (2017)
Killing two birds with one stone: dual blockade of integrin and FGF signaling through targeting syndecan-4 in postoperative capsular opacification
Yingyan Qin et al.
CELL DEATH & DISEASE (2017)
IGF-IR cooperates with ERα to inhibit breast cancer cell aggressiveness by regulating the expression and localisation of ECM molecules
Nikolaos A. Afratis et al.
SCIENTIFIC REPORTS (2017)
Microenvironmental regulation of tumour angiogenesis
Michele de Palma et al.
NATURE REVIEWS CANCER (2017)
Circulating microRNAs as Biomarkers for Pediatric Astrocytomas
Javier Enrique Lopez-Aguilar et al.
ARCHIVES OF MEDICAL RESEARCH (2017)
Shed proteoglycans in tumor stroma
Zoi Piperigkou et al.
CELL AND TISSUE RESEARCH (2016)
Functional Importance of a Proteoglycan Coreceptor in Pathologic Lymphangiogenesis
Scott C. Johns et al.
CIRCULATION RESEARCH (2016)
Metastatic osteosarcoma: a challenging multidisciplinary treatment
Cristina Meazza et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2016)
Syndecan-4 expression is upregulated in endometriosis and contributes to an invasive phenotype
Anca Chelariu-Raicu et al.
FERTILITY AND STERILITY (2016)
Estrogen receptor beta modulates breast cancer cells functional properties, signaling and expression of matrix molecules
Zoi Piperigkou et al.
MATRIX BIOLOGY (2016)
Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials
Heleen. H. Van Acker et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Proteoglycans in liver cancer
Kornelia Baghy et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
New structural insight of C-terminal region of Syntenin-1, enhancing the molecular dimerization and inhibitory function related on Syndecan-4 signaling
Youngsil Choi et al.
SCIENTIFIC REPORTS (2016)
Targeting of CCL2-CCR2-Glycosaminoglycan Axis Using a CCL2 Decoy Protein Attenuates Metastasis through Inhibition of Tumor Cell Seeding
Marko Roblek et al.
NEOPLASIA (2016)
Regulatory Roles of MAPK Phosphatases in Cancer
Heng Boon Low et al.
IMMUNE NETWORK (2016)
Syndecan-4 as a biomarker to predict clinical outcome for glioblastoma multiforme treated with WT1 peptide vaccine
Satoshi Takashima et al.
FUTURE SCIENCE OA (2016)
Transglutaminase 2 interacts with syndecan-4 and CD44 at the surface of human macrophages to promote removal of apoptotic cells
Vinod Nadella et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2015)
Heparan Sulphate as a Regulator of Leukocyte Recruitment in Inflammation
Archana V. Kumar et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2015)
Syndecan-1 and Syndecan-4 Capture Epidermal Growth Factor Receptor Family Members and the α3β1 Integrin Via Binding Sites in Their Ectodomains NOVEL SYNSTATINS PREVENT KINASE CAPTURE AND INHIBIT α6β4-INTEGRIN-DEPENDENT EPITHELIAL CELL MOTILITY
Haiyao Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Trans-regulation of Syndecan Functions by Hetero-oligomerization
Youngsil Choi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Transmembrane proteoglycans control stretch-activated channels to set cytosolic calcium levels
Sandeep Gopal et al.
JOURNAL OF CELL BIOLOGY (2015)
Syndecan-4 Regulates Muscle Differentiation and Is Internalized from the Plasma Membrane during Myogenesis
Sissel B. Ronning et al.
PLOS ONE (2015)
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets
Mark A. Feitelson et al.
SEMINARS IN CANCER BIOLOGY (2015)
Latent Heparanase Facilitates VLA-4-Mediated Melanoma Cell Binding and Emerges As a Relevant Target of Heparin in the Interference with Metastatic Progression
Ursula Gerber et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2015)
Metalloproteinase-dependent and -independent processes contribute to inhibition of breast cancer cell migration, angiogenesis and liver metastasis by a disintegrin and metalloproteinase with thrombospondin motifs-15
Richard Kelwick et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Thyroid Cancer
Tobias Carling et al.
ANNUAL REVIEW OF MEDICINE, VOL 65 (2014)
The extracellular matrix modulates the hallmarks of cancer
Michael W. Pickup et al.
EMBO REPORTS (2014)
Matrix metalloproteinase 9-mediated shedding of syndecan 4 in response to tumor necrosis factor α : a contributor to endothelial cell glycocalyx dysfunction
Raina Ramnath et al.
FASEB JOURNAL (2014)
MicroRNA regulation of proteoglycan function in cancer
Sherif A. Ibrahim et al.
FEBS JOURNAL (2014)
Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancer
Tibor Szarvas et al.
HUMAN PATHOLOGY (2014)
Cytoplasmic Domain Interactions of Syndecan-1 and Syndecan-4 with α6β4 Integrin Mediate Human Epidermal Growth Factor Receptor (HER1 and HER2)-dependent Motility and Survival
Haiyao Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Heparan Sulfate Proteoglycans and Human Breast Cancer Epithelial Cell Tumorigenicity
Rachel K. Okolicsanyi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2014)
Stromal heparan sulfate differentiates neuroblasts to suppress neuroblastoma growth
Erik H. Knelson et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Syndecan-4 Knockout Leads to Reduced Extracellular Transglutaminase-2 and Protects against Tubulointerstitial Fibrosis
Alessandra Scarpellini et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Acquisition of Anoikis Resistance Up-Regulates Syndecan-4 Expression in Endothelial Cells
Bruna Ribeiro Carneiro et al.
PLOS ONE (2014)
Up-regulation of TGM2 with ITGB1 and SDC4 is important in the development and metastasis of renal cell carcinoma
Merve Erdem et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Specific genes involved in synthesis and editing of heparan sulfate proteoglycans show altered expression patterns in breast cancer
Ivan Fernandez-Vega et al.
BMC CANCER (2013)
Syndecan-4 Phosphorylation Is a Control Point for Integrin Recycling
Mark R. Morgan et al.
DEVELOPMENTAL CELL (2013)
Contribution of syndecans to lipoplex-mediated gene delivery
Tamas Letoha et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Expression of matrix macromolecules and functional properties of EGF-responsive colon cancer cells are inhibited by panitumumab
Ch. Gialeli et al.
INVESTIGATIONAL NEW DRUGS (2013)
The Syndecan-4/Protein Kinase Cα Pathway Mediates Prostaglandin E2-induced Extracellular Regulated Kinase (ERK) Activation in Endothelial Cells and Angiogenesis in Vivo
Federico Corti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Syndecan-4 signaling at a glance
Arye Elfenbein et al.
JOURNAL OF CELL SCIENCE (2013)
Xentry, a new class of cell-penetrating peptide uniquely equipped for delivery of drugs
Kristopher Montrose et al.
SCIENTIFIC REPORTS (2013)
Expression of Syndecan-4 and Correlation with Metastatic Potential in Testicular Germ Cell Tumours
Vassiliki T. Labropoulou et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Expression of matrix macromolecules and functional properties of breast cancer cells are modulated by the bisphosphonate zoledronic acid
P. G. Dedes et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
Mda-9/Syntenin Is Expressed in Uveal Melanoma and Correlates with Metastatic Progression
Rosaria Gangemi et al.
PLOS ONE (2012)
Syndecan-4 proteoliposomes enhance fibroblast growth factor-2 (FGF-2)-induced proliferation, migration, and neovascularization of ischemic muscle
Eugene Jang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Syndecan 4 Regulates FGFR1 Signaling in Endothelial Cells by Directing Macropinocytosis
Arye Elfenbein et al.
SCIENCE SIGNALING (2012)
A Syndecan-4 Hair Trigger Initiates Wound Healing through Caveolin- and RhoG-Regulated Integrin Endocytosis
Mark D. Bass et al.
DEVELOPMENTAL CELL (2011)
Rspo3 Binds Syndecan 4 and Induces Wnt/PCP Signaling via Clathrin-Mediated Endocytosis to Promote Morphogenesis
Bisei Ohkawara et al.
DEVELOPMENTAL CELL (2011)
Syndecan-1 and Syndecan-4 Are Independent Indicators in Breast Carcinoma
Maria E. Lendorf et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2011)
Syndecan-4 promotes cytokinesis in a phosphorylation-dependent manner
Aniko Keller-Pinter et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Proteoglycans in health and disease: the multiple roles of syndecan shedding
Tina Manon-Jensen et al.
FEBS JOURNAL (2010)
Focal amplifications are associated with high grade and recurrences in stage Ta bladder carcinoma
Helena Nord et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Non-canonical Wnt Signaling Induces Ubiquitination and Degradation of Syndecan
Loreto Carvallo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Preclinical pharmacology of CGP 42′446, a new, potent, heterocyclic bisphosphonate compound
Jonathan R. Green et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Extracellular matrix rigidity modulates neuroblastoma cell differentiation and N-myc expression
Wilbur A. Lam et al.
MOLECULAR CANCER (2010)
The expression of syndecan-1, syndecan-4 and decorin in healthy human breast tissue during the menstrual cycle
Gunilla Hallberg et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2010)
Syndecan-1 and syndecan-4 are involved in RANTES/CCL5-induced migration and invasion of human hepatoma cells
Faten Charni et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2009)
Glycosaminoglycans and syndecan-4 are involved in SDF-1/CXCL12-mediated invasion of human epitheloid carcinoma HeLa cells
Severine Brule et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2009)
How ERK1/2 activation controls cell proliferation and cell death is subcellular localization the answer?
Yohannes Mebratu et al.
CELL CYCLE (2009)
Fibroblast growth factor-2 modulates melanoma adhesion and migration through a syndecan-4-dependent mechanism
Georgia Chalkiadaki et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Cleavage of syndecan-4 by ADAMTS1 provokes defects in adhesion
Juan Carlos Rodriguez-Manzaneque et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
EXPRESSION OF BASIC FIBROBLAST GROWTH FACTOR, ITS RECEPTORS AND SYNDECANS IN BLADDER CANCER
D. Marzioni et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2009)
Heparan Sulfate Proteoglycan Modulation of Wnt5A Signal Transduction in Metastatic Melanoma Cells
Michael P. O'Connell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Suppression of RhoG activity is mediated by a syndecan 4-synectin-RhoGDI1 complex and is reversed by PKCα in a Rac1 activation pathway
Arye Elfenbein et al.
JOURNAL OF CELL BIOLOGY (2009)
Cell Surface and Secreted Protein Profiles of Human Thyroid Cancer Cell Lines Reveal Distinct Glycoprotein Patterns
Arthur Arcinas et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis
Frank Echtermeyer et al.
NATURE MEDICINE (2009)
Targeting Heparan Sulfate Proteoglycans in Breast Cancer Treatment
Chuay-Yeng Koo et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2008)
Changes in heparan sulfate are associated with delayed wound repair, altered cell migration, adhesion and contractility in the galactosyltransferase I (β4GalT-7) deficient form of Ehlers-Danlos syndrome
Martin Goette et al.
HUMAN MOLECULAR GENETICS (2008)
Sndecan-4-dependent Rac1 regulation determines directional migration in response to the extracellular matrix
Mark D. Bass et al.
JOURNAL OF CELL BIOLOGY (2007)
Integrins and syndecan-4 make distinct, but critical, contributions to adhesion contact formation
Mark D. Bass et al.
SOFT MATTER (2007)
Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion
Angela Sutton et al.
MOLECULAR CANCER RESEARCH (2007)
Melanoma genomics reveals signatures of sensitivity to bio- and targeted therapies
J. Timar et al.
CELLULAR IMMUNOLOGY (2006)
Syndecan-1 and syndecan-4 are overexpressed in an estrogen receptor-negative, highly proliferative breast carcinoma subtype
Fusun Baba et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9
Severine Brule et al.
GLYCOBIOLOGY (2006)
Expression of syndecans, a heparan sulfate proteoglycan, in malignant gliomas:: participation of nuclear factor-κB in upregulation of syndecan-1 expression
Arata Watanabe et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Specific structural features of syndecans and heparan sulfate chains are needed for cell signaling
CC Lopes et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2006)
Therapeutic value of glycosaminoglycans in cancer
George W. Yip et al.
MOLECULAR CANCER THERAPEUTICS (2006)
The role of syndecans in disease and wound healing
Constance Y. Fears et al.
MATRIX BIOLOGY (2006)
Heparan sulfate proteoglycans function as receptors for fibroblast growth factor-2 activation of extracellular signal-regulated kinases 1 and 2
CC Chua et al.
CIRCULATION RESEARCH (2004)
Hypoxia induces adhesion molecules on cancer cells: A missing link between Warburg effect and induction of selectin-ligand carbohydrates
T Koike et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Syndecan-2 mediates adhesion and proliferation of colon carcinoma cells
H Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Protein kinase C regulation of glypican-1, syndecan-1 and syndecan-4 mRNAs expression during rat Sertoli cell development
S Brucato et al.
BIOCHIMIE (2002)
Regulation of glypican-1, syndecan-1 and syndecan-4 mRNAs expression by follicle-stimulating hormone, cAMP increase and calcium influx during rat Sertoli cell development
S Brucato et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2002)
Fibroblast growth factor-specific modulation of cellular response by syndecan-4
A Horowitz et al.
JOURNAL OF CELL BIOLOGY (2002)
Cellular and molecular properties associated with osteosarcoma cells
D Benayahu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2002)
Cell adhesion in tumor invasion and metastasis: loss of the glue is not enough
U Cavallaro et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2001)
Structural requirements of heparan sulfate for the binding to the tumor-derived adhesion factor/angiomodulin that induces cord-like structures to ECV-304 human carcinoma cells
J Kishibe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
